Serato, Antonio C.
HRN: 00-66-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2024
CEFTAZIDIME 1GM (VIAL)
03/14/2024
03/21/2024
IVT
1g
Q8
CAP HR; Pleural Effusion Left
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes